Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) <sup>18</sup>F-Radiopharmaceuticals
The incorporation of silicon fluoride acceptor (SiFA) moieties into a variety of molecules, such as peptides, proteins and biologically relevant small molecules, has improved the generation of <sup>18</sup>F-radiopharmaceuticals for medical imaging. The efficient isotopic exchange radiof...
Saved in:
Main Authors: | Lexi Gower-Fry (Author), Travis Kronemann (Author), Andreas Dorian (Author), Yinglan Pu (Author), Carolin Jaworski (Author), Carmen Wängler (Author), Peter Bartenstein (Author), Leonie Beyer (Author), Simon Lindner (Author), Klaus Jurkschat (Author), Björn Wängler (Author), Justin J. Bailey (Author), Ralf Schirrmacher (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
by: Simon Blok, et al.
Published: (2023) -
Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022) -
Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
by: Carmen Wängler, et al.
Published: (2022) -
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA<i>lin</i>-Modified Peptidic Radioligands Targeting Both Integrin α<sub>v</sub>β<sub>3</sub> and the MC1 Receptor-Suitable for the Specific Visualization of Melanomas?
by: Xia Cheng, et al.
Published: (2021) -
Radiosynthesis of Stable <sup>198</sup>Au-Nanoparticles by Neutron Activation of α<sub>v</sub>β<sub>3</sub>-Specific AuNPs for Therapy of Tumor Angiogenesis
by: Güllü Davarci, et al.
Published: (2023)